Adoptive immunotherapy may help treat more types of Cancer

"Adoptive cell therapy is currently one of the most intensely researched strategies within cancer treatment, and in recent years we have seen some truly promising advances in treating certain types of cancer," said Jonathan Wilkinson. ACT is a personalized cancer therapy that involves generating tumor-targeting cultures from tumor-infiltrating lymphocytes, and then reintroducing them to the patient. The cells are reintroduced with interleukin-2 and have been shown to lead to tumor regression. "The early promise of adoptive immuno-therapy is now coming to fruition, with exciting clinical responses being reported against various cancers."